Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology - PubMed

Comparative Study

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology

R E Banks et al. Br J Cancer. 1998 Mar.

Free PMC article

Abstract

Vascular endothelial growth factor (VEGF) is a potent angiogenic factor with a key role in several pathological processes, including tumour vascularization. Our preliminary observations indicated higher VEGF concentrations in serum samples than in matched plasma samples. We have now demonstrated that this difference is due to the presence of VEGF within platelets and its release upon their activation during coagulation. In eight healthy volunteers, serum VEGF concentrations ranged from 76 to 854 pg ml(-1) and were significantly higher (P < 0.01) than the matched citrated plasma VEGF concentrations, which ranged from < 9 to 42 pg ml(-1). Using platelet-rich plasma, mean (s.d.) platelet VEGF contents of 0.56 (0.36) pg of VEGF 10(-6) platelets were found. Immunocytochemistry demonstrated the cytoplasmic presence of VEGF within megakaryocytes and other cell types within the bone marrow. From examination of the effects of blood sample processing on circulating VEGF concentrations, it is apparent that for accurate measurements, citrated plasma processed within 1 h of venepuncture should be used. Serum is completely unsuitable. The presence of VEGF within platelets has implications for processes involving platelet and endothelial cell interactions. e.g. wound healing, and in tumour metastasis, when platelets adhering to circulating tumour cells may release VEGF at points of adhesion to endothelium, leading to hyperpermeability and extravasation of cells.

Comment in

• Blood platelets and serum VEGF in cancer patients.

  Vermeulen PB, Salven P, Benoy I, Gasparini G, Dirix LY. Vermeulen PB, et al. Br J Cancer. 1999 Jan;79(2):370-3. doi: 10.1038/sj.bjc.6690059. Br J Cancer. 1999. PMID: 9888483 Free PMC article. No abstract available.

Similar articles

• Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen?

  Lee JK, Hong YJ, Han CJ, Hwang DY, Hong SI. Lee JK, et al. Int J Oncol. 2000 Jul;17(1):149-52. Int J Oncol. 2000. PMID: 10853032

• Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo?

  Wynendaele W, Derua R, Hoylaerts MF, Pawinski A, Waelkens E, de Bruijn EA, Paridaens R, Merlevede W, van Oosterom AT. Wynendaele W, et al. Ann Oncol. 1999 Aug;10(8):965-71. doi: 10.1023/a:1008377921886. Ann Oncol. 1999. PMID: 10509160 Clinical Trial.

• A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful?

  Hormbrey E, Gillespie P, Turner K, Han C, Roberts A, McGrouther D, Harris AL. Hormbrey E, et al. Clin Exp Metastasis. 2002;19(8):651-63. doi: 10.1023/a:1021379811308. Clin Exp Metastasis. 2002. PMID: 12553370 Review.

• Pitfalls in the measurement of circulating vascular endothelial growth factor.

  Jelkmann W. Jelkmann W. Clin Chem. 2001 Apr;47(4):617-23. Clin Chem. 2001. PMID: 11274009 Review.

Cited by

• Angiogenesis is an independent prognostic factor in malignant mesothelioma.

  Edwards JG, Cox G, Andi A, Jones JL, Walker RA, Waller DA, O'Byrne KJ. Edwards JG, et al. Br J Cancer. 2001 Sep 14;85(6):863-8. doi: 10.1054/bjoc.2001.1997. Br J Cancer. 2001. PMID: 11556838 Free PMC article.

• Vascular endothelial growth factor in ovarian cancer.

  Hazelton DA, Hamilton TC. Hazelton DA, et al. Curr Oncol Rep. 1999 Sep;1(1):59-63. doi: 10.1007/s11912-999-0011-9. Curr Oncol Rep. 1999. PMID: 11122799 Review.

• The Correlation Between Platelet Count and Survival in Prostate Cancer.

  Mezei T, Bőde I, Tenke P, Jósa V, Merkel K, Szilasi Z, Tordai A, Máthé D, Baranyai Z. Mezei T, et al. Res Rep Urol. 2022 May 6;14:193-202. doi: 10.2147/RRU.S359715. eCollection 2022. Res Rep Urol. 2022. PMID: 35572814 Free PMC article.

• Vascular endothelial growth factor plasma levels in depression and following electroconvulsive therapy.

  Ryan KM, McLoughlin DM. Ryan KM, et al. Eur Arch Psychiatry Clin Neurosci. 2018 Dec;268(8):839-848. doi: 10.1007/s00406-018-0919-x. Epub 2018 Jul 2. Eur Arch Psychiatry Clin Neurosci. 2018. PMID: 29968119

• Roxadustat promotes hypoxia-inducible factor-1α/vascular endothelial growth factor signalling to enhance random skin flap survival in rats.

  Lan Q, Wang K, Meng Z, Lin H, Zhou T, Lin Y, Jiang Z, Chen J, Liu X, Lin Y, Lin D. Lan Q, et al. Int Wound J. 2023 Nov;20(9):3586-3598. doi: 10.1111/iwj.14235. Epub 2023 May 24. Int Wound J. 2023. PMID: 37225176 Free PMC article.

References

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Nature Publishing Group
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database